Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Physiological evidence for diversification of IFNα- and IFNβ-mediated response programs in different autoimmune diseases.
pERK1/2 Peripheral Recruitment and Filopodia Protrusion Augment Oligodendrocyte Progenitor Cell Migration: Combined Effects of PDGF-A and Fibronectin.
Purkinje cell dysfunction and delayed death in plasma membrane calcium ATPase 2-heterozygous mice.
Aquaporin 4 Expression and Tissue Susceptibility to Neuromyelitis Optica.
Efficacy of Fish Oil on Serum of TNF α , IL-1 β , and IL-6 Oxidative Stress Markers in Multiple Sclerosis Treated with Interferon Beta-1b.
Validity and reliability of the FSS in Greek MS patients.
Act1 mediates IL-17-induced EAE pathogenesis selectively in NG2(+) glial cells.
MicroRNAs and multiple sclerosis: from physiopathology toward therapy.
Guideline for the diagnosis and management of multiple sclerosis: A Southern African perspective.
Disconnection of the hippocampus and amygdala associated with lesion load in relapsing-remitting multiple sclerosis: a structural and functional connectivity study.
[A Case of Neuromyelitis Optica with Relapse Symptoms from Paroxysmal Pruritus].
Role of Tumor Necrosis Factor Superfamily in Neuroinflammation and Autoimmunity.
Dysfunction in Motor Coordination in Neonatal White Matter Injury Model without Apparent Neuron Loss.
Rescue from acute neuroinflammation by pharmacological chemokine-mediated deviation of leukocytes.
Can we predict the evolution of an unpredictable disease like multiple sclerosis?
Benign course of tumour-like multiple sclerosis. Report of five cases and literature review.
Microwave & magnetic (M(2) ) proteomics of the EAE animal model of multiple sclerosis.
Relapse of multiple sclerosis in a patient retaining CCR7-expressing T cells in CSF under fingolimod therapy.
Immune-mediated inflammatory diseases: progress in molecular pathogenesis and therapeutic strategies.
Insights into multiple sclerosis provided by non-coding RNAs: meeting summary from the symposium 'Non-coding RNAs in autoimmune disorders of the central nervous system' on 5 April 2013 in Warsaw, Poland.
MRI measures of neurodegeneration in multiple sclerosis: implications for disability, disease monitoring, and treatment.
Anthocyanins suppress the secretion of proinflammatory mediators and oxidative stress, and restore ion pump activities in demyelination.
Novel diagnostic tools and solutions for multiple sclerosis treatment: a patent review (2009 - 2014).
Oligoclonal restriction of antiviral immunoreaction in oligoclonal band-negative MS patients.
Osmotic Demyelination Syndrome as the Initial Manifestation of a Hyperosmolar Hyperglycemic State.

Pages